missing translation for 'onlineSavingsMsg'
Learn More

Cytokeratin 13 Mouse anti-Human, Clone: KRT13/2659, Novus Biologicals™

Mouse Monoclonal Antibody

Marque:  Novus Biologicals NBP3-07847-20UG

Code nomenclature Nacres: NA.46

 Afficher plus de versions de ce produit

Product Code. 18354102

  • 272.00€ / 20µg

Veuillez vous pour pouvoir commander cet article. Besoin d'un compte web? Créer le vôtre dès maintenant!

This item is not returnable. View return policy

Description

Description

Cytokeratin 13 Monoclonal specifically detects Cytokeratin 13 in Human samples. It is validated for Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Cytokeratin 13
Monoclonal
0.2 mg/ml
Flow Cytometry 1-2 ug per million cells, Immunohistochemistry, Immunocytochemistry/Immunofluorescence 1-2 ug/ml, Immunohistochemistry-Paraffin
CK13, CK-13, cytokeratin 13, Cytokeratin-13, K13cytokeratin-13, keratin 13, keratin, type I cytoskeletal 13, keratin-13, MGC161462, MGC3781
Recombinant full-length human Cytokeratin 13 protein
20 μg
Cell Biology, Cellular Markers
3860
Store at 4°C.
IgG1 κ
Flow Cytometry, Immunohistochemistry, Immunofluorescence, Immunohistochemistry (Paraffin)
KRT13/2659
Unconjugated
10 mM PBS with 0.05% BSA
Mouse
Protein A or G purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.